Orgenesis (ORGS)
(Delayed Data from NSDQ)
$4.08 USD
-0.41 (-9.13%)
Updated Sep 26, 2024 04:00 PM ET
After-Market: $4.01 -0.07 (-1.72%) 7:58 PM ET
NA Value
NA Growth NA Momentum NA VGMBalance Sheet
Fiscal Year End for Orgenesis Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1 | 6 | 6 | 46 | 12 |
Receivables | 1 | 36 | 15 | 3 | 11 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 2 |
Other Current Assets | 2 | 4 | 4 | 1 | 1 |
Total Current Assets | 4 | 46 | 26 | 50 | 26 |
Net Property & Equipment | 1 | 23 | 10 | 3 | 24 |
Investments & Advances | 0 | 0 | 0 | 0 | 1 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 9 | 18 | 20 | 22 | 29 |
Deposits & Other Assets | 0 | 1 | 2 | 1 | 3 |
Total Assets | 15 | 91 | 60 | 78 | 93 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 7 | 4 | 5 | 9 | 11 |
Current Portion Long-Term Debt | 3 | 5 | 6 | 4 | 1 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 2 | 3 | 0 | 1 | 2 |
Income Taxes Payable | 1 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 3 | 4 | 3 | 2 | 15 |
Total Current Liabilities | 16 | 16 | 15 | 16 | 32 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 2 |
Convertible Debt | 19 | 13 | 5 | 7 | 12 |
Long-Term Debt | 0 | 0 | 0 | 0 | 1 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 1 |
Other Non-Current Liabilities | 0 | 1 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 30 | 0 | 0 | 31 |
Total Liabilities | 36 | 62 | 21 | 25 | 86 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 157 | 150 | 146 | 140 | 95 |
Retained Earnings | -177 | -121 | -106 | -88 | -89 |
Other Equity | 0 | 1 | 0 | 1 | 1 |
Treasury Stock | 1 | 1 | 1 | 0 | 0 |
Total Shareholder's Equity | -21 | 29 | 39 | 53 | 6 |
Total Liabilities & Shareholder's Equity | 15 | 91 | 60 | 78 | 93 |
Total Common Equity | -21 | 29 | 39 | 53 | 6 |
Shares Outstanding | 31.80 | 25.50 | 24.20 | 24.10 | 16.10 |
Book Value Per Share | -0.66 | 1.14 | 1.60 | 2.19 | 0.38 |
Fiscal Year End for Orgenesis Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 1 | 1 | 1 | 1 | 1 |
Receivables | 0 | 0 | 1 | 1 | 1 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Other Current Assets | 1 | 1 | 2 | 7 | 7 |
Total Current Assets | 2 | 2 | 4 | 9 | 9 |
Net Property & Equipment | 16 | 16 | 1 | 2 | 1 |
Investments & Advances | 0 | 0 | 0 | 23 | 32 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 10 | 10 | 9 | 11 | 11 |
Deposits & Other Assets | 0 | 0 | 0 | 1 | 1 |
Total Assets | 31 | 31 | 15 | 45 | 55 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 13 | 16 | 7 | 5 | 4 |
Current Portion Long-Term Debt | 3 | 3 | 3 | 3 | 2 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 3 | 4 | 2 | 2 | 2 |
Income Taxes Payable | 1 | 1 | 1 | 1 | 1 |
Other Current Liabilities | 11 | 4 | 3 | 3 | 3 |
Total Current Liabilities | 32 | 29 | 16 | 14 | 13 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 0 | 0 |
Convertible Debt | 5 | 20 | 19 | 18 | 18 |
Long-Term Debt | 3 | 3 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 5 | 0 | 0 | 0 | |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 46 | 58 | 36 | 33 | 31 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 181 | 160 | 157 | 156 | 155 |
Retained Earnings | -195 | -186 | -177 | -142 | -130 |
Other Equity | 0 | 0 | 0 | 0 | 0 |
Treasury Stock | 1 | 1 | 1 | 1 | 1 |
Total Shareholder's Equity | -16 | -28 | -21 | 12 | 24 |
Total Liabilities & Shareholder's Equity | 31 | 31 | 15 | 45 | 55 |
Total Common Equity | -16 | -28 | -21 | 12 | 24 |
Shares Outstanding | 46.90 | 34.30 | 31.80 | 28.40 | 28.30 |
Book Value Per Share | -0.34 | -0.80 | -0.66 | 0.44 | 0.85 |